• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

爱尔兰的高危家族性结直肠癌筛查服务:临床结果的批判性综述

High-risk family colorectal cancer screening service in Ireland: Critical review of clinical outcomes.

作者信息

Walshe Margaret, Moran Robert, Boyle Marie, Cretu Ion, Galvin Zita, Swan Victoria, Trikovic Jason, Farrell Michael P, Foy Sinéad, O'Brien Loretta, Leyden Jan, Mulligan Niall, Fenlon Helen, Gallagher David J, MacMathúna Padraic

机构信息

Gastrointestinal Unit, Mater Misericordiae University Hospital, University College Dublin, Eccles Street, Dublin 7, Ireland.

Gastrointestinal Unit, Mater Misericordiae University Hospital, University College Dublin, Eccles Street, Dublin 7, Ireland.

出版信息

Cancer Epidemiol. 2017 Oct;50(Pt A):30-38. doi: 10.1016/j.canep.2017.07.002. Epub 2017 Aug 4.

DOI:10.1016/j.canep.2017.07.002
PMID:28783501
Abstract

BACKGROUND

We present the 15-year experience of a family colorectal cancer screening service in Ireland with emphasis on real life experience and outcomes.

METHODS

Questionnaires were used to assess family cancer history and assign patients to risk categories; 'Moderate Risk', HNPCC, (suspected) genetic syndrome (non-HNPCC), 'Low Risk'. Screening was by full colonoscopy. We report neoplastic yield, examining effect of risk category, age, gender, and index colonoscopy findings.

RESULTS

Between 1998 and 2013, 2242 individuals were referred; 57.3% female, 42.7% male, median age 46 years (range9-85yrs). Median follow up time was 7.9yrs (range 0.5-15.3yrs). Follow up data after exclusion (non-compliance, known CRC) was available in 1496 (66.7%): 'Moderate risk' 785 (52.5%), HNPCC 256 (17.1%), (suspected) genetic syndrome (non-HNPCC) 85 (5.7%), 'Low Risk' 370 (24.7%). Screening was performed in 1025(68.5%) patients; colonoscopy data available for 993 (96.9%); total 1914 colonoscopies. At index colonoscopy, 178 (18.0%) patients had adenomas; 56 (5.5%) advanced adenoma. During the entire study period, 240 (24.2%) had an adenoma; 69 (7.0%) advanced adenoma. Cancers were diagnosed on screening in 2 patients. Older age and male gender were associated with higher adenoma detection rate; p<0.001, p=0.01, respectively. Risk category did not affect adenoma yield. Adenoma and advanced adenoma detection at index colonoscopy were associated with detection of same at follow up screening; p<0.001.

CONCLUSION

Male gender and age (>50) were the core identifiable risk factors for neoplasia at screening colonoscopy in this family screening setting. Our results would support less intensive surveillance in younger patients (<50), particularly where index colonoscopy is normal.

摘要

背景

我们介绍了爱尔兰一项为期15年的家族性结直肠癌筛查服务经验,重点是实际经验和结果。

方法

采用问卷调查评估家族癌症病史,并将患者分为风险类别;“中度风险”、遗传性非息肉病性结直肠癌(HNPCC)、(疑似)遗传综合征(非HNPCC)、“低风险”。筛查采用全结肠镜检查。我们报告肿瘤检出率,研究风险类别、年龄、性别和首次结肠镜检查结果的影响。

结果

1998年至2013年期间,共转诊2242人;女性占57.3%,男性占42.7%,中位年龄46岁(范围9 - 85岁)。中位随访时间为7.9年(范围0.5 - 15.3年)。排除(不依从、已知结直肠癌)后的随访数据在1496人中可用(66.7%):“中度风险”785人(52.5%),HNPCC 256人(17.1%),(疑似)遗传综合征(非HNPCC)85人(5.7%),“低风险”370人(24.7%)。1025名(68.5%)患者接受了筛查;993名(96.9%)患者有结肠镜检查数据;共进行了1914次结肠镜检查。在首次结肠镜检查时,178名(18.0%)患者发现腺瘤;56名(5.5%)为进展性腺瘤。在整个研究期间,240名(24.2%)患者发现腺瘤;69名(7.0%)为进展性腺瘤。筛查中诊断出2例癌症。年龄较大和男性与较高的腺瘤检出率相关;p<0.001,p = 0.01,风险类别不影响腺瘤检出率。首次结肠镜检查时腺瘤和进展性腺瘤的检出与随访筛查时的检出相关;p<0.001。

结论

在这个家族筛查环境中,男性和年龄(>50岁)是筛查结肠镜检查时肿瘤形成的核心可识别风险因素。我们的结果支持对年轻患者(<50岁)进行强度较低的监测,特别是在首次结肠镜检查正常的情况下。

相似文献

1
High-risk family colorectal cancer screening service in Ireland: Critical review of clinical outcomes.爱尔兰的高危家族性结直肠癌筛查服务:临床结果的批判性综述
Cancer Epidemiol. 2017 Oct;50(Pt A):30-38. doi: 10.1016/j.canep.2017.07.002. Epub 2017 Aug 4.
2
Neoplasia at 10-year follow-up screening colonoscopy in a private U.S. practice: comparison of yield to first-time examinations.10 年随访筛查结肠镜检查中的新生物:与首次检查相比的检出率。
Gastrointest Endosc. 2018 Jan;87(1):254-259. doi: 10.1016/j.gie.2017.04.035. Epub 2017 May 4.
3
[Distribution characteristics and risk factors of colorectal adenomas].[结直肠腺瘤的分布特征及危险因素]
Zhonghua Wei Chang Wai Ke Za Zhi. 2018 Jun 25;21(6):678-684.
4
Adenoma and advanced neoplasia detection rates increase from 45 years of age.腺瘤和高级别瘤变的检出率从 45 岁开始增加。
World J Gastroenterol. 2019 Jan 28;25(4):447-456. doi: 10.3748/wjg.v25.i4.447.
5
Increased risk of colorectal neoplasia among family members of patients with colorectal cancer: a population-based study in Utah.结直肠癌患者家庭成员结直肠肿瘤发病风险增加:犹他州基于人群的研究。
Gastroenterology. 2014 Oct;147(4):814-821.e5; quiz e15-6. doi: 10.1053/j.gastro.2014.07.006. Epub 2014 Jul 17.
6
Colorectal cancer risk factors in the detection of advanced adenoma and colorectal cancer.结直肠腺瘤和结直肠癌检测中的结直肠癌危险因素。
Cancer Epidemiol. 2013 Jun;37(3):278-83. doi: 10.1016/j.canep.2013.02.004. Epub 2013 Mar 9.
7
Intermediate-risk patients with three to four small adenomas should be considered low risk for colorectal cancer screening.对于有 3-4 个小腺瘤的中危患者,应考虑其结直肠癌筛查的风险较低。
Dig Endosc. 2016 May;28(4):450-455. doi: 10.1111/den.12570. Epub 2015 Dec 9.
8
Adenoma, advanced adenoma and colorectal cancer prevalence in asymptomatic 40- to 49-year-old subjects with a first-degree family history of colorectal cancer.腺瘤、高级别腺瘤及结直肠癌在一级亲属有结直肠癌病史的 40-49 岁无症状人群中的流行情况。
Colorectal Dis. 2013 Sep;15(9):1093-9. doi: 10.1111/codi.12263.
9
Adenoma Detection Rate in Colonoscopy: Is Indication a Predictor?结肠镜检查中的腺瘤检出率:指征是一个预测指标吗?
Surg Laparosc Endosc Percutan Tech. 2016 Apr;26(2):156-61. doi: 10.1097/SLE.0000000000000253.
10
Equivalency of fecal immunochemical tests and colonoscopy in familial colorectal cancer screening.粪便免疫化学检测与结肠镜检查在家族性结直肠癌筛查中的等效性。
Gastroenterology. 2014 Nov;147(5):1021-30.e1; quiz e16-7. doi: 10.1053/j.gastro.2014.08.004. Epub 2014 Aug 13.

引用本文的文献

1
Mutation Analysis of KRAS and BRAF in Iranian Colorectal Cancer patients: A Novel Variant in Exon 15 of BRAF.伊朗结直肠癌患者 KRAS 和 BRAF 的突变分析:BRAF 外显子 15 的新变异体。
Asian Pac J Cancer Prev. 2023 Nov 1;24(11):3665-3671. doi: 10.31557/APJCP.2023.24.11.3665.
2
Low Incidence of Colorectal Advanced Neoplasia During Surveillance in Individuals with a Family History of Colorectal Cancer.有结直肠癌家族史个体在监测期间结直肠高级别瘤变的低发病率
Dig Dis Sci. 2023 Nov;68(11):4243-4251. doi: 10.1007/s10620-023-08053-6. Epub 2023 Sep 8.
3
Evidenced-Based Screening Strategies for a Positive Family History.
基于证据的阳性家族史筛查策略。
Gastrointest Endosc Clin N Am. 2020 Jul;30(3):597-609. doi: 10.1016/j.giec.2020.02.015. Epub 2020 Apr 14.